Docket Room
SB 1795·MO·senate

Creates provisions relating to biomarker testing

FailedFiled Feb 26, 2026
Sponsor: Stephen Webber (D)
Latest Action

Second Read and Referred S Families, Seniors and Health Committee

May 7, 2026

Summary

The bill directs the state Medicaid program (MO HealthNet) to pay for biomarker testing when it has proven clinical utility, and it obligates private insurers, nonprofit plans, and HMOs that issue contracts after August 28 2026 to do the same. It also sets up an easy‑to‑use exception process and limits the need for multiple biopsies. The measure does not require coverage for screening tests.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when SB 1795 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice